NASDAQ: NXTCNextcure Inc Stock Ownership - Who owns Nextcure?
Insider buying vs selling
Have Nextcure Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adar1 Capital Management LLC | 10% Owner | 2026-10-27 | 3,553 | $5.10 | $18.10kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-10-26 | 1,672 | $5.03 | $8.42kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-10-23 | 5,626 | $4.83 | $27.17kBuy |
| Simcere Zaiming Inc | Insider | 2026-08-10 | 30,000 | $6.16 | $184.80kSell |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-31 | 3,300 | $4.98 | $16.42kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-31 | 25,000 | $4.98 | $124.55kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-31 | 8,003 | $4.80 | $38.41kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-30 | 100,000 | $4.90 | $490.00kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-30 | 50,000 | $4.97 | $248.60kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-07-30 | 20,000 | $5.00 | $100.00kBuy |
NXTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NXTC insiders and whales buy or sell their stock.
NXTC Shareholders
What type of owners hold Nextcure Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Chau Quang Khuong | 59.23% | 2,711,013 | $17.69M | Insider |
| Orbimed Advisors LLC | 59.23% | 2,711,013 | $17.69M | Insider |
| Sofinnova Venture Partners IX LP | 58.37% | 2,671,856 | $17.43M | Insider |
| Timothy M. 1. Shannon | 49.25% | 2,254,442 | $14.71M | Insider |
| Canaan X LP | 49.25% | 2,254,442 | $14.71M | Insider |
| Stella Xu | 24.11% | 1,103,570 | $7.20M | Insider |
| Adar1 Capital Management LLC | 16.02% | 733,270 | $4.78M | Insider |
| Simcere Zaiming Inc | 14.14% | 647,272 | $4.22M | Insider |
| Alexandria Venture Investments LLC | 4.33% | 197,993 | $1.29M | Insider |
| Linda Liu | 1.21% | 55,234 | $360.40k | Insider |
NXTC vs Biotech Stocks
Nextcure Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.